IRIDEX Investor Relations Material
Latest events
Q1 2025
IRIDEX
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from IRIDEX Corp
Access all reports
IRIDEX Corp is a medical technology company specializing in the development and commercialization of innovative laser-based systems for the treatment of eye diseases. The company’s products are primarily used in ophthalmology for the treatment of glaucoma, retinal diseases, and other vision-threatening conditions. IRIDEX’s laser systems and related consumables are designed to provide precise and minimally invasive treatment options for patients, improving outcomes and reducing recovery times. The company is headquartered in Mountain View, California, USA, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
IRIX
Country
🇺🇸 United States